Literature DB >> 18758848

HA/GSA-Rmax ratio as a predictor of postoperative liver failure.

Masaki Kaibori1, Sang Kil Ha-Kawa, Morihiko Ishizaki, Kosuke Matsui, Takamichi Saito, A-Hon Kwon, Yasuo Kamiyama.   

Abstract

BACKGROUND: Postoperative mortality after hepatectomy remains high compared with other types of surgery in patients who have cirrhosis or chronic hepatitis. Although there are several useful perioperative markers of liver dysfunction, there are no standard markers for predicting postoperative liver failure. This study investigated risk factors for postoperative liver failure after resection of hepatocellular carcinoma to detect markers that could identify candidates for hepatectomy.
METHODS: Perioperative risk factors for liver failure after hepatectomy were analyzed in 191 patients with hepatocellular carcinoma. Multivariate logistic regression analysis was done to investigate factors with a significant independent influence among 35 variables. The ratio of serum hyaluronic acid to the maximum removal rate of technetium-99 m diethylenetriaminepentaacetic acid galactosyl human serum albumin (hyaluronate/GSA-Rmax ratio) was calculated.
RESULTS: Liver failure occurred postoperatively in 16 patients, 3 of whom died. The hyaluronate/GSA-Rmax ratio was a risk factor for postoperative liver failure by univariate analysis and was the only risk factor according to multivariate analysis. All three patients who died had a hyaluronic acid/GSA-Rmax ratio > or = 500 mg min/dl. This ratio had a sensitivity of 88% and a specificity of 92% for predicting liver failure.
CONCLUSIONS: To reduce postoperative liver failure, preoperative planning should employ various measures of the hepatic functional reserve, including tests of both parenchymal and nonparenchymal liver function. The hyaluronate/GSA-Rmax ratio can predict liver failure after hepatectomy, and a ratio > or = 500 mg min/dl is a relative contraindication to liver resection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758848     DOI: 10.1007/s00268-008-9725-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  63 in total

1.  Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass.

Authors:  M Kudo; A Todo; K Ikekubo; M Hino; Y Yonekura; K Yamamoto; K Torizuka
Journal:  Gastroenterol Jpn       Date:  1991-12

2.  Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: support for the intact-hepatocyte theory.

Authors:  B Meyer; H S Luo; M Bargetzi; E L Renner; G A Stalder
Journal:  Hepatology       Date:  1991-03       Impact factor: 17.425

3.  Estimation of risk of major complications after hepatic resection.

Authors:  M Shimada; T Matsumata; K Akazawa; T Kamakura; H Itasaka; K Sugimachi; Y Nose
Journal:  Am J Surg       Date:  1994-04       Impact factor: 2.565

4.  Liver resective surgery: a multivariate analysis of postoperative outcome and complication.

Authors:  Enrico Benzoni; Alessandro Cojutti; Dario Lorenzin; Gian Luigi Adani; Umberto Baccarani; Alessandro Favero; Aron Zompicchiati; Fabrizio Bresadola; Alessandro Uzzau
Journal:  Langenbecks Arch Surg       Date:  2006-09-16       Impact factor: 3.445

5.  Removal rate of [3H]hyaluronan injected subcutaneously in rabbits.

Authors:  R K Reed; U B Laurent; J R Fraser; T C Laurent
Journal:  Am J Physiol       Date:  1990-08

6.  Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.

Authors:  Y Murawaki; Y Ikuta; K Okamoto; M Koda; H Kawasaki
Journal:  J Gastroenterol       Date:  2001-06       Impact factor: 7.527

7.  Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy.

Authors:  Toru Mizuguchi; Tadashi Katsuramaki; Takayuki Nobuoka; Masaki Kawamoto; Hideki Oshima; Hiroyuki Kawasaki; Hitoshi Kikuchi; Chihiro Shibata; Koichi Hirata
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

8.  Comparison of sulphated glycosaminoglycan and hyaluronate synthesis and secretion in cultured hepatocytes, fat storing cells, and Kupffer cells.

Authors:  A M Gressner; S Schäfer
Journal:  J Clin Chem Clin Biochem       Date:  1989-03

9.  Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma.

Authors:  T Seki; M Wakabayashi; T Nakagawa; T Itho; T Shiro; K Kunieda; M Sato; S Uchiyama; K Inoue
Journal:  Cancer       Date:  1994-08-01       Impact factor: 6.860

10.  Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

Authors:  S T Fan; E C Lai; C M Lo; I O Ng; J Wong
Journal:  Arch Surg       Date:  1995-02
View more
  9 in total

1.  Fused 99m-Tc-GSA SPECT/CT imaging for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve?

Authors:  Morikatsu Yoshida; Shinya Shiraishi; Fumi Sakaguchi; Daisuke Utsunomiya; Kuniyuki Tashiro; Seiji Tomiguchi; Hirohisa Okabe; Toru Beppu; Hideo Baba; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2012-04       Impact factor: 2.374

2.  Bone marrow cells enhance liver regeneration after massive hepatectomy in mice.

Authors:  Masaki Kaibori; Yasushi Adachi; Tomohiko Shimo; Morihiko Ishizaki; Kosuke Matsui; Yoshito Tanaka; Masaharu Ohishi; Yoshiro Araki; Katsuji Tokuhara; Tadayoshi Okumura; Mikio Nishizawa; A-Hon Kwon
Journal:  Dig Dis Sci       Date:  2014-01-23       Impact factor: 3.199

Review 3.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand?

Authors:  Kelly Lafaro; Stefan Buettner; Hadia Maqsood; Doris Wagner; Fabio Bagante; Gaya Spolverato; Li Xu; Ihab Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-11       Impact factor: 3.452

4.  Significance of (99m)Tc-GSA liver scintigraphy in liver surgery and transplantation.

Authors:  Taku Iida; Shintaro Yagi; Tomohide Hori; Shinji Uemoto
Journal:  Ann Transl Med       Date:  2015-02

5.  Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review.

Authors:  Federico Tomassini; Mariano C Giglio; Giuseppe De Simone; Roberto Montalti; Roberto I Troisi
Journal:  Updates Surg       Date:  2020-08-04

6.  Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver.

Authors:  Yukinori Tanoue; Atsushi Nanashima; Koichi Yano; Yoshirou Fujii; Masahide Hiyoshi; Naoya Imamura; Takeomi Hamada; Makoto Ikenoue; Takashi Wada; Yoichi Mizutani; Toshinori Hirai
Journal:  Nucl Med Commun       Date:  2019-02       Impact factor: 1.690

7.  Liver-to-spleen ratio as an index of chronic liver diseases and safety of hepatectomy: a pilot study.

Authors:  Yangqing Huang; Bin Huang; Tong Kan; Boshuai Yang; Min Yuan; Jiefei Wang
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

8.  A quantitative index measured on ⁹⁹mTc GSA SPECT/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease.

Authors:  Morikatsu Yoshida; Shinya Shiraishi; Fumi Sakaguchi; Daisuke Utsunomiya; Kuniyuki Tashiro; Seiji Tomiguchi; Hirohisa Okabe; Toru Beppu; Hideo Baba; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2012-04-12       Impact factor: 2.374

9.  Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with (99m)Tc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice.

Authors:  Deliang Zhang; Zhide Guo; Pu Zhang; Yesen Li; Xinhui Su; Linyi You; Mengna Gao; Chang Liu; Hua Wu; Xianzhong Zhang
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.